HanYang University Medical Center (HYUMC) Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-01-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The HYUMC registry is a two-center, real-world registry of percutaneous coronary intervention in patients with coronary artery disease. From January 2012, PCI-treated patients from Hanyang University Seoul Hospitals and Hanyang University Guri Hospitals were enrolled in this registry.

The aim of this registry is to examine the long-term clinical outcomes and identify predictors of adverse outcomes following percutaneous coronary intervention conducted at academic hospitals.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prospective Pecutaneous Coronary Intervention Registry

NCT05624905

Coronary Artery Disease Percutaneous Coronary Intervention

RECRUITING

KOMATE Registry: Korean Multicenter Angioplasty Team

NCT03908463

Coronary Artery Disease Acute Coronary Syndrome Myocardial Infarction +1 more

RECRUITING

Long-term Outcomes and Prognostic Factors in Patient Undergoing CABG or PCI

NCT03870815

Ischemic Heart Disease

RECRUITING

Physiologic Assessment of Microvascular Function in Heart Transplant Patients

NCT02798731

Cardiac Allograft Vasculopathy

RECRUITING

Impact of Gut Microbiota on Clinical Outcomes and Left Ventricular Remodeling After Primary Percutaneous Coronary Intervention

NCT07175181

Primary Percutaneous Coronary Intervention

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the HYUMC registry, the researchers have gathered and assessed various demographic, laboratory, echocardiographic, and angiographic measurements (both on-admission and during follow-up), as well as conducted questionnaires among patients who underwent percutaneous coronary intervention. The primary focus of this registry is to examine the effects of these parameters on long-term clinical outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Stenosis Coronary Artery Disease Blood Pressure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients with CAD undergoing PCI

patients with CAD undergoing PCI with second generation DES

percutaneous coronary intervention

Intervention Type DEVICE

patients with CAD undergoing PCI with second generation DES

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

percutaneous coronary intervention

patients with CAD undergoing PCI with second generation DES

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Consecutive patients with CAD who underwent PCI one or more drug eluting stent (DES) with from 2012 at the Division of Cardiology of Hanyang University Seoul Hospital and Hanyang University Guri Hospital, Korea.

Exclusion Criteria

* second or subsequent hospitalization records of patients with multiple admissions
* patients who died during index hospitalization
* patients who treated with first-generation drug eluting stent
* patients with an outpatient follow-up record of less than 6 months
* patients with insufficient medical records.

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No